|
|
Random Topics - Varenicline (trade name Chantix)
Varenicline (trade name Chantix in the USA and Champix in Canada, Europe and other countries, marketed by Pfizer, usually in the form of varenicline tartrate), is a prescription medication used to treat smoking addiction. Varenicline is a nicotinic receptor partial agonist. In this respect it is similar to cytisine and different from the nicotinic antagonist, bupropion, and nicotine replacement therapies (NRTs) like nicotine patches (commonly, "the patch") and nicotine gum. As a partial agonist it both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products. Through these mechanisms it can assist some patients to quit smoking.
The US Food and Drug Administration requires Chantix (varenicline) and Zyban (bupropion) to carry a black box warning, the agency's strongest safety warning, due to public reports of side effects including depression, suicidal thoughts, and suicidal actions[1].
Wikipedia Link: http://en.wikipedia.org/wiki/Varenicline
eBay Link: View Varenicline (trade name Chantix) on eBay
|
|
| # | Comments |
| 1 |
Damn! Smokers are better off to continue to smoke! -- Submitted By: (Stephanie) on May 28, 2011, 2:27 pm - (0 votes)
- Login to Vote
|
| 2 |
Usually when these products run TV ads warning about 27 different potentially scary side-effects, viewers are bound to chuckle. In this case, those warnings are clearly no laughing matter. I sure hope nobody I know is taking this stuff. -- Submitted By: (Soggy9000) on May 28, 2011, 5:58 am - (1 votes)
- Login to Vote
|
| 3 |
Smoking-pill suicides overlooked in missing reports
Hundreds of reports of suicides, psychotic reactions and other serious problems tied to the popular stop-smoking drug Chantix were left out of a crucial government safety review because Pfizer Inc., the drug’s manufacturer, submitted years of data through “improper channels.”
Some 150 suicides — more than doubling those previously known — were among 589 delayed reports of severe issues turned up in a new analysis by the non-profit Institute for Safe Medication Practices.
-- Submitted By: (lrbloom) on May 28, 2011, 3:16 am - (0 votes)
- Login to Vote
|
|
|
Login to See the QUICK COMMENT Box
|
Follow on Twitter!
|